Skip to main content

Advertisement

Contact Naoyoshi Onoda

From: Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)

Contact corresponding author